The American Academy of Pediatrics (AAP) expressed concern over misleading claims made during a recent White House event on autism, which included unsubstantiated suggestions that separating vaccines might reduce the risk of autism. These claims, made by President Donald J. Trump and federal health officials, have been widely criticized for sending confusing messages to parents and potentially putting children’s health at risk.
“Spreading unfounded and harmful information about vaccines and medications undermines public health efforts and jeopardizes the well-being of children,” said AAP President Susan J. Kressly, M.D., FAAP. “Pediatricians know that vaccines are critical for protecting children from serious diseases like polio, measles, and whooping cough. Delaying or spreading out vaccines exposes children to preventable diseases when they are most vulnerable.”
The Centers for Disease Control and Prevention (CDC) recently reported that 1 in 31 children are now diagnosed with autism. Despite this, the notion that altering vaccination schedules could reduce autism risk remains unsupported by evidence. “Children’s immune systems function best when they receive vaccines on time, ensuring they are protected from contagious diseases,” Dr. Kressly added.
Additionally, the Food and Drug Administration (FDA) has begun reviewing the use of acetaminophen during pregnancy, citing concerns over possible links to neurodevelopmental disorders like autism and ADHD. However, experts, including Steven J. Fleischman, M.D., FACOG, president of the American College of Obstetricians and Gynecologists, have refuted these claims, emphasizing that extensive research has found no credible connection between acetaminophen use during pregnancy and autism. “Suggestions like this are not only harmful but also deeply confusing to pregnant patients, who may rely on this medication for safe pain management,” Dr. Fleischman said.
The FDA also initiated the approval process for leucovorin calcium tablets, intended to treat cerebral folate deficiency (CFD), a condition that can contribute to developmental delays and autism-like symptoms. While some early research suggests leucovorin may improve verbal communication in some children, the AAP cautioned that more extensive clinical trials are needed to determine its effectiveness.
“Autism has no single cause and no universal treatment,” Dr. Kressly emphasized. “Effective interventions require a tailored approach that often includes a combination of therapies, educational support, and social-relational strategies.”
The AAP continues to urge policymakers to increase funding for research and resources to support families of children with autism, including therapies like speech and occupational therapy. The National Institutes of Health (NIH) has launched the Autism Data Science Initiative, committing over $50 million to better understand autism and its rising prevalence.
For parents seeking reliable information on autism, vaccines, and related treatments, the AAP encourages consulting with a pediatrician. The Academy remains steadfast in its commitment to supporting scientific research and ensuring that families have access to accurate, evidence-based guidance.
Leave a Reply